The global hypercholesterolemia market size reached US$ 17.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 58.2 Billion by 2032, exhibiting a growth rate (CAGR) of 13.74% during 2024-2032. Rising health consciousness, increasing geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the ma... https://www.imarcgroup.com/hypercholesterolemia-market